Patents by Inventor Haley Neff-LaFord

Haley Neff-LaFord has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
    Publication number: 20240075134
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: September 20, 2023
    Publication date: March 7, 2024
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20240075135
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: September 20, 2023
    Publication date: March 7, 2024
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
    Publication number: 20230201344
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: November 9, 2022
    Publication date: June 29, 2023
    Inventors: Shyra Gardai, Che-Leung LAW, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20230201343
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: November 2, 2022
    Publication date: June 29, 2023
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • METHODS OF TREATING MULTIPLE MYELOMA
    Publication number: 20230118517
    Abstract: Provided herein are methods of treating multiple myeloma (MM) using specific doses of an anti-B-cell migration antigen (BCMA) antibody, various dosing regimens, and optionally combination therapy with dexamethasone, an immunomodulatory agent (e.g., pomalinamide), an anti-CD38 antibody or antigen binding fragment thereof (e.g., daratumumab), and a gamma secretase inhibitor (GSI), and/or various combinations thereof.
    Type: Application
    Filed: March 25, 2021
    Publication date: April 20, 2023
    Inventors: Mary Campbell, Heather Van Epps, Haley Neff-LaFord, Celine Fabienne Jacquemont, David Taft, Hong Li
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY
    Publication number: 20220265822
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: May 2, 2022
    Publication date: August 25, 2022
    Inventors: Shyra Gardai, Che-Leung LAW, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20220249662
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 11, 2022
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • Dosage and administration of non-fucosylated anti-CD40 antibodies
    Patent number: 11213584
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: January 4, 2022
    Assignee: Seagen Inc.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • Dosage and administration of non-fucosylated anti-CD40 antibodies
    Patent number: 11202827
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: December 21, 2021
    Assignee: Seagen Inc.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20170333556
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: October 29, 2015
    Publication date: November 23, 2017
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord
  • DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
    Publication number: 20170137528
    Abstract: This invention relates methods of using a non-fucosylated anti-CD40 antibody for treatment of cancer and chronic infectious diseases.
    Type: Application
    Filed: January 20, 2017
    Publication date: May 18, 2017
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Shyra Gardai, Che-Leung Law, Stanford Peng, Jing Yang, Haley Neff-LaFord, Thomas John Manley